Genetic analysis of 17 genes in Staphylococcus aureus with reduced susceptibility to vancomycin (VISA) and heteroVISA.

1. Waren, D. K., Kollef, M. H., Seiler, S. M. et al. (2003). The epidemiology of vancomycin-resistant Enterococcus colonization in a medical intensive care unit. Infection Control and Hospital Epidemiology 24, 257–63. 2. Bíliková, E., Hanzen, J., Roidová, A. et al. (2001). Bacteraemia due to vancomycin-resistant enterococci in Slovakia. Journal of Antimicrobial Chemotherapy 47, 357–68. 3. Dutka-Malen, S., Evers, S. & Courvalin, P. (1995). Detection of glycopeptide resistance genotypes and identification to the species level of clinically relevant enterococci by PCR. Journal of Clinical Microbiology 33, 24–7. 4. Kariyama, R., Mitsuhatu, R., Chow, J. W. et al. (2000). Simple and reliable multiplex PCR assay for surveillance isolates of vancomycinresistant enterococci. Journal of Clinical Microbiology 38, 3092–5. 5. Kuriyama, T., Williams, D. W., Patel, M. et al. (2003). Molecular characterization of clinical and environmental isolates of vancomycinresistant Enterococcus faecium and Enterococcus faecalis from a teaching hospital in Wales. Journal of Medical Microbiology 52, 821–7. 6. National Committee for Clinical Laboratory Standards. (2000). Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically—Fifth Edition: Approved Standard M7-A4. NCCLS, Villanova, PA, USA. 7. Swenson, J. M., Ferraro, M. J., Sahm, D. F. et al. (1995). Multilaboratory evaluation of screening methods for detection of high-level aminoglycoside resistance in enterococci. Journal of Clinical Microbiology 33, 3008–18. Journal of Antimicrobial Chemotherapy DOI: 10.1093/jac/dkh086 Advance Access publication 16 January 2004